Virtus ETF Advisers’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,784
| Closed | -$174K | – | 457 |
|
|
2022
Q1 | $174K | Sell |
11,784
-698
| -6% | -$10.3K | 0.08% | 209 |
|
|
2021
Q4 | $165K | Buy |
12,482
+4,988
| +67% | +$65.9K | 0.06% | 309 |
|
|
2021
Q3 | $131K | Sell |
7,494
-399
| -5% | -$6.98K | 0.06% | 362 |
|
|
2021
Q2 | $189K | Buy |
+7,893
| New | +$189K | 0.08% | 371 |
|
|
2019
Q4 | – | Sell |
-12,688
| Closed | -$147K | – | 483 |
|
|
2019
Q3 | $147K | Sell |
12,688
-707
| -5% | -$8.19K | 0.03% | 277 |
|
|
2019
Q2 | $297K | Buy |
+13,395
| New | +$297K | 0.06% | 219 |
|